U.S. flag

An official website of the United States government

GTR Home > Genes

APOA1 apolipoprotein A1

Gene ID: 335, updated on 11-Jan-2025
Gene type: protein coding
Also known as: AMYLD3; HPALP2; apo(a)

Summary

This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The encoded preproprotein is proteolytically processed to generate the mature protein, which promotes cholesterol efflux from tissues to the liver for excretion, and is a cofactor for lecithin cholesterolacyltransferase (LCAT), an enzyme responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein. [provided by RefSeq, Dec 2015]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
A genome wide association study identifies common variants associated with lipid levels in the Chinese population.
GeneReviews: Not available
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
GeneReviews: Not available
Biological, clinical and population relevance of 95 loci for blood lipids.
GeneReviews: Not available
Common variants at 30 loci contribute to polygenic dyslipidemia.
GeneReviews: Not available
Discovery and refinement of loci associated with lipid levels.
GeneReviews: Not available
Familial amyloid polyneuropathy, Iowa type
MedGen: C4551500OMIM: 620657GeneReviews: Not available
not available
Genetic variants influencing circulating lipid levels and risk of coronary artery disease.
GeneReviews: Not available
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
GeneReviews: Not available
Genome-wide association study identifies multiple loci influencing human serum metabolite levels.
GeneReviews: Not available
Genome-wide association study of hematological and biochemical traits in a Japanese population.
GeneReviews: Not available
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides.
GeneReviews: Not available
Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci.
GeneReviews: Not available
Hypoalphalipoproteinemia, primary, 2
MedGen: C5551172OMIM: 618463GeneReviews: Not available
See labs
Hypoalphalipoproteinemia, primary, 2, intermediate
MedGen: C5677030OMIM: 619836GeneReviews: Not available
See labs
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
GeneReviews: Not available
Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.
GeneReviews: Not available
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.
GeneReviews: Not available
Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
GeneReviews: Not available
Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.
GeneReviews: Not available
Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis.
GeneReviews: Not available
Salt-inducible kinase 3, SIK3, is a new gene associated with hearing.
GeneReviews: Not available
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.
GeneReviews: Not available
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
GeneReviews: Not available

Genomic context

Location:
11q23.3
Sequence:
Chromosome: 11; NC_000011.10 (116835751..116837622, complement)
Total number of exons:
4

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.